Healthcare >> CEO Interviews >> October 17, 2003

Nicholas Landekic – Polymedix Inc

NICHOLAS LANDEKIC is President, Director, co-Founder and Chief Executive Officer of PolyMedix, Inc. He has been in the pharmaceutical and biotechnology industry for over 20 years, and has done some of the largest and most important financing and corporate licensing deals in the healthcare industry. From 2000 to 2002, he was President and Chief Executive Officer and the first employee of Locus Discovery, where in two years he raised $83 million in two record-breaking venture financings, hired over 50 employees, started 12 drug discovery programs, built one of the most powerful supercomputers in the world, and earned for the company the accolade 'One of the 10 hottest biotech startups' from Drug Discovery Today magazine. Prior to Locus, from 1995 to 2000 he was Senior Vice President, Corporate Development and Investor Relations at Guilford Pharmaceuticals, where he concluded a $465 million deal with Amgen and a $100 million deal with Rhone-Poulenc Rorer. His deals have twice been nominated for 'Allicense Deal of the Year.' Prior to Guilford, from 1991 to 1995, he was Senior. Director, Business Development at Cephalon; from 1988-1991 Senior Manager, Strategic Marketing at Bristol-Myers Squibb; from 1985 to 1988, he held positions in Finance and Business Development at Johnson & Johnson Corporation (McNeil Pharmaceutical); and he also worked in the research laboratories at the Mt. Sinai Medical Center from 1982 to 1983. He holds an MBA from the State University of New York at Albany, an MS in Biology from Indiana University and a BS in Biology from Marist College. Profile
TWST: Could we start out with a brief history and quick overview of


Mr. Landekic: Polymedix is a young company. We were formed about one

year ago. The company really was born when